SGLT2 Inhibitors: A New Therapeutical Strategy to Improve Clinical Outcomes in Patients with Chronic Kidney Diseases

SGLT2 Inhibitors: A New Therapeutical Strategy to Improve Clinical Outcomes in Patients with Chronic Kidney Diseases

The purpose of this manuscript is to review the effects of sodium-glucose cotransport protein 2 inhibitors (SGLT2is) in patients with chronic kidney disease according to basic mechanisms, current recommendations, and future perspectives. Based on growing evidence from randomized, controlled trials,...

Full description

Bibliographic Details
Main Authors: Assunta Di Costanzo, Giovanni Esposito, Ciro Indolfi, Carmen Anna Maria Spaccarotella
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:International Journal of Molecular Sciences
Subjects:
SGLT2 inhibitors
type 2 diabetes mellitus
cardiovascular disease
heart failure
chronic kidney disease
Online Access:https://www.mdpi.com/1422-0067/24/10/8732

Internet

https://www.mdpi.com/1422-0067/24/10/8732

Similar Items